期刊
CURRENT OPINION IN PHARMACOLOGY
卷 11, 期 5, 页码 446-452出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2011.06.011
关键词
-
资金
- Pfizer
- European Commission [241796, LSHP-CT-2007-037941]
- Swiss National Science Foundation [3200B0-122324/1]
- University of Geneva Hospitals, Geneva, Switzerland
This review presents recent evidence regarding the adverse effects of antibiotic therapy mediated by collateral damage to commensal flora. Two major drivers have characterized recent research in this field: new perspectives into human microbiota afforded by next-generation DNA sequencing techniques and ongoing attention to antimicrobial resistance. New molecular techniques have illustrated that antibiotic therapy can disturb human microbiota, and that these changes are associated with infection. Concurrently, epidemiologic studies using patient-level data offer new insights into the role of antibiotics in the emergence, selection and spread of antimicrobial resistance, and Clostridium difficile infection (CDI).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据